SV Health Investors is a specialist healthcare fund manager that backs innovative companies across biotechnology, healthtech, and medical device sectors. It leverages dedicated funds to support early‑stage through growth‑stage ventures, with a strong focus on dementia therapeutics and transformative medtech. The firm seeks to generate impact and financial returns by partnering with founders who address unmet medical needs.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United Kingdom
29.6%United States of America
25.9%Canada
11.1%Australia
3.7%Brazil
3.7%Other
14.8%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Dementia Discovery Fund DDF-2
Vintage 2025 • $269M
SV Life Sciences Fund IV
Vintage 2022 • $412.1M
Medtech Convergence Fund LP
Vintage 2019 • $75M
DDF Parallel LLP
Vintage 2017 • $19.3M
Dementia Discovery LP
Vintage 2016 • $169.6M
SV7 Growth Fund LP
Vintage 2019 • $136M
SV Life Sciences Fund VI Strategic Partners LP
Vintage 2017 • $13.3M